39 Six year follow up of the European Multicentre Randomised Study comparing Navelbine (NVB) alone vs NVB + Cisplatin (CDDP) vs Vindesine (VDS) + CDDP in 612 patients (pts) with advanced non-small cell lung cancer (NSCLC)

Authors :: D. Brisgand
A. Riviere
Pierre Ruffié
J.Y. Douilard
J.L. Pujol
Vicente Alberola
A. Panizo
José Luis González Larriba
P. Danel
P.F. Besson
V. Guillem
P. Berthaud
A. Monnier
T. Le Chevalier
S. Cigolari
Ana Maria Blanco Martinez
Source :: Lung Cancer. 18:13
Publication Year :: 1997
Publisher :: Elsevier BV, 1997.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
business.industry
non-small cell lung cancer (NSCLC)
medicine.disease
Internal medicine
medicine
Vindesine
business
medicine.drug

Full Text Access

Tools